Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Promega Assay Reagents to Support Complement-ARIE…

U.S. Department Of Health And Human Services·Maryland

Promega Assay Reagents to Support Complement-ARIE Mechanistic Toxicology Research

Closes 9/21/2026$5k – $15kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) through its National Institute of Environmental Health Sciences (NIEHS) is seeking quotations for a set of Promega assay reagents to support the Complement-ARIE mechanistic toxicology research program. The reagents will be used in human three‑dimensional microphysiological systems to evaluate cell viability, liver injury, liver function, oxidative stress, antioxidant responses, and cellular bioenergetics. The Government intends to award a firm‑fixed‑price purchase order on a sole‑source basis to Promega Corporation, but all responsible sources may submit quotations that meet the technical specifications. Delivery is required by September 25 2026 to the NIEHS facility in Research Triangle Park, NC. Quotations must be submitted via email by 12:00 pm Eastern Time on September 21 2026. • Solicitation ID: 75N98026Q01226 (RFQ) • Required products: eight specific Promega assay kits (CellTiter‑Glo, LDH‑Glo, Triglyceride‑Glo, ROS‑Glo, Lactate‑Glo, P450‑Glo, GSH‑Glo) in listed quantities • Delivery location: NIEHS, Rall Building 101, Labs E144‑146, RTP, NC 27709 • Contract type: Firm‑fixed‑price, sole‑source but open to all qualified quotations • Mandatory submission deadline: 12:00 pm ET, 21 Sep 2026 • Contact: Jordan Neal (Contract Specialist, NIH)

Attached files

Contact

Jordan Neal

[email protected]

Key dates

Opened
9/16/2026
Closes
9/21/2026

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
325413
Solicitation №
75N98026Q01226

Budget estimate

$5,000 – $15,000

The solicitation does not disclose a total dollar value. Based on the listed quantities (total of 26 assay kits) and typical market prices for Promega kits (approximately $200‑$600 per kit depending on format), the estimated procurement value likely falls between $5,000 and $15,000. Factors influencing the final amount include exact unit pricing, any volume discounts, and shipping costs to North Carolina.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 68%

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

68% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. National Institutes of Health·United States of America

66% match

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)

Closes 1/4/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

65% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. Centers for Disease Control - NCEH·United States of America

65% match

State Biomonitoring Cooperative Agreement

Closes 5/18/2027Opened 9/22/2026

U.S. Food and Drug Administration·United States of America

65% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

65% match

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Closes 1/7/2028Opened 10/28/2024

U.S. Food and Drug Administration·United States of America

65% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Veterans Affairs·Texas

65% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Veterans Affairs·Washington

65% match

Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.

Closes 11/13/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

64% match

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Closes 10/8/2027Opened 11/21/2024

Iowa State University·Iowa

64% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

Colorado Department of Public Health and Environment (CDPHE)·Colorado

64% match

Qiagen EZ2 reagents and consumables

Closes 11/2/2026Opened 10/28/2026

U.S. Geological Survey·United States of America

64% match

Cooperative Agreement for affiliated Partner with Northern Great Plains Cooperative Ecosystem Studies Unit

Closes 11/14/2026Opened 10/14/2026

U.S. National Institutes of Health·United States of America

64% match

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/4/2024

U.S. Department Of Health And Human Services·United States of America

64% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

64% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

University of Massachusetts·Massachusetts

64% match

UMass Amherst University Health Services - Laboratory and/or Clinical Molecular Analyzer

Closes 11/6/2026Opened 10/5/2026

U.S. Department Of Veterans Affairs·California

64% match

6550--Blood Type IVD Reagents

Closes 11/16/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

64% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

63% match

DoW Toxic Exposures Investigator Initiated Research Award

Closes 11/19/2026Opened 5/7/2026

U.S. National Institutes of Health·United States of America

63% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

63% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

63% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/23/2023

U.S. Department Of Health And Human Services·Maryland

63% match

Reagents and consumables for Roche immunostainers

Closes 11/16/2026Opened 10/30/2026